Cite
van Oort S, Rutters F, Warlé-van Herwaarden MF, et al. Characteristics associated with polypharmacy in people with type 2 diabetes: the Dutch Diabetes Pearl cohort. Diabet Med. 2020;38(4):e14406doi: 10.1111/dme.14406.
van Oort, S., Rutters, F., Warlé-van Herwaarden, M. F., Schram, M. T., Stehouwer, C. D., Tack, C. J., Abbink, E. J., Wolffenbuttel, B. H., van der Klauw, M. M., DeVries, J. H., Siegelaar, S. E., Sijbrands, E. J., Özcan, B., de Valk, H. W., Silvius, B., Schroijen, M. A., Jazet, I. M., van Ballegooijen, A. J., Beulens, J. W. J., Elders, P. J., Kramers, C. (2021). Characteristics associated with polypharmacy in people with type 2 diabetes: the Dutch Diabetes Pearl cohort. Diabetic medicine : a journal of the British Diabetic Association, 38(4), e14406. https://doi.org/10.1111/dme.14406
van Oort, S, et al. "Characteristics associated with polypharmacy in people with type 2 diabetes: the Dutch Diabetes Pearl cohort." Diabetic medicine : a journal of the British Diabetic Association vol. 38,4 (2021): e14406. doi: https://doi.org/10.1111/dme.14406
van Oort S, Rutters F, Warlé-van Herwaarden MF, Schram MT, Stehouwer CD, Tack CJ, Abbink EJ, Wolffenbuttel BH, van der Klauw MM, DeVries JH, Siegelaar SE, Sijbrands EJ, Özcan B, de Valk HW, Silvius B, Schroijen MA, Jazet IM, van Ballegooijen AJ, Beulens JWJ, Elders PJ, Kramers C. Characteristics associated with polypharmacy in people with type 2 diabetes: the Dutch Diabetes Pearl cohort. Diabet Med. 2021 Apr;38(4):e14406. doi: 10.1111/dme.14406. Epub 2020 Oct 17. PMID: 32961611; PMCID: PMC8048843.
Copy
Download .nbib